Pramipexol "Aurobindo" 0,35 mg tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "aurobindo" 0,35 mg tabletter

aurobindo pharma (malta) limited - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg

Pramipexol "Aurobindo" 0,7 mg tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "aurobindo" 0,7 mg tabletter

aurobindo pharma (malta) limited - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg

Pramipexol "Bluefish" 0,18 mg tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,18 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,18 mg

Pramipexol "Bluefish" 0,35 mg tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,35 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,35 mg

Pramipexol "Bluefish" 0,7 mg tabletter Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

pramipexol "bluefish" 0,7 mg tabletter

bluefish pharmaceuticals ab - pramipexoldihydrochloridmonohydrat - tabletter - 0,7 mg

Solu-medrol 1 g pulver og solvens til injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

solu-medrol 1 g pulver og solvens til injektionsvæske, opløsning

pfizer aps - methylprednisolonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 1 g

Solu-medrol 500 mg pulver og solvens til injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

solu-medrol 500 mg pulver og solvens til injektionsvæske, opløsning

pfizer aps - methylprednisolonnatriumsuccinat - pulver og solvens til injektionsvæske, opløsning - 500 mg

Edistride Avrupa Birliği - Danca - EMA (European Medicines Agency)

edistride

astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotika anvendt i diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillæg til andre lægemidler til behandling af type 2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.